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Between 2007–2014, there have been considerable changes in the use of different types of detector systems at mam-
mography facilities undertaking screening programs in Poland. The use of screen-film systems (termed SF systems) 
has largely decreased and been replaced by either computed radiography (termed CR systems) or digital radiography 
systems (termed DR systems); this inevitably affecting mean glandular dose values. The study aim was to evaluate 
changes of mean glandular dose values for a dose exposure of 4.5 cm (MGD4,5cmPMMA) achieved by using different image 
detectors. The study consisted of analysing 1499 protocols for quality control tests carried out by medical physicists 
at 16 Regional Coordination Offices in 2007, 2011, 2012 and 2013. The mean CR system values were higher than for 
SF systems; by 25% in 2011, by 26% in 2012, and by 28% in 2013. In subsequent years, the MGD4,5cmPMMA mean values 
for DR systems were higher than for SF systems by respectively 15%, 4% and 5%. Also in the subsequent years, the 
MGD4,5cmPMMA mean values for CR systems were higher than for DR systems by respectively 13%, 23% and 24%. In all 
cases, the MGD4,5cmPMMA mean values were within the acceptable level of 2.5 mGy. The MGD4,5cmPMMA mean values 
were different, depending on the detection system used for mammography screening in Poland.
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Introduction
In Poland, the ’Polish National Breast Cancer Early De-
tection Program for Women aged from 50 to 69’ has been 
undertaken since 2006 where such women underwent 
mammography examination. Each woman was examined 
every second year. Until 2015, the program was managed 
by a Central Coordination Office at the Maria Skłodowska-
Curie Memorial Centre and Institute of Oncology in Warsaw 
together with 16 Regional Coordination Offices in each 
region (voivodeship) in Poland [1]. The coordination of-
fices were chiefly responsible for assuring the quality of 
mammography screening examinations. For this purpose 
medical physicists at each mammography facility carried out 
quality control tests of mammography equipment consist-
ing of: X-ray beam geometry, breast compression, spatial 
resolution, threshold contrast, artefacts, compensation of 
phantom thickness changes and high voltage values gen-
erated by the Automatic Exposure Control (AEC) systems, 
routine exposure times and the conditions and quality of 
the mammography image display. Moreover, the mean glan-
dular dose values for an exposure of a 4.5 cm thick phan-
tom were determined (later called MGD4,5cmPMMA). Between 
2007–2008 and between 2011–2015, all the mammography 
facilities carrying out screening examinations in Poland were 
quality controlled. During 2009 and 2010 however, quality 
control was performed for only those mammography fa-
cilities which had the worst outcomes in the previous year 
as well as those, which in any given year, had been part of 
the screening programs. In 2009, 200/340 mammography 
units (about 59%) were quality assessed, and in 2010, 271/ 
/325 (about 83%).
Over 2007–2009 screening was either performed solely 
for those mammography units with film detector systems 
(termed screen-film systems — SF) or with digital detectors 
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(termed digital radiography systems — DR). Since 2010 and 
according to President of the National Health Fund regula-
tions, systems with an imaging plate (made of photosimu-
lable phosphor, termed computed radiography systems 
— CR) have been included in the screening program. Within 
recent years, the SF systems have been gradually replaced 
by CR and DR systems, which thereby must have affected 
the radiation doses received by the women examined. The 
study aim was to evaluate changes in the MGD4,5cmPMMA 
doses when using different image detectors.
Materials and methods
The study consisted of analysing 1499 protocols of qual-
ity control tests carried out by medical physicists at 16 
Regional Coordination Offices in 2007, 2011, 2012 and 
2013. The quality control covered those parameters of 
mammography systems responsible for image quality and 
MGD4,5cmPMMA of which the outcomes from 2007 and 2011 
were published in the Nowotwory Journal of Oncology [2]. 
For this study only the MGD4,5cmPMMA dose values for the 
4.5 cm thick PMMA phantom were analysed. Addition-
ally, on the basis of the above mentioned protocols, the 
numbers of mammography units with particular detector 
types SF, CR, and DR, were established. The numbers of 
mammography units taking part in the screening program 
for 2014 were obtained from the Central Coordination 
Office report [3].
Determination of MGD4,5cmPMMA 
Medical physicists from each Regional Coordination 
Office measured MGD4,5cmPMMA doses according to the meth-
ods published in ‘Additional factors for the estimation of 
mean glandular breast dose using the UK mammography 
dosimetry protocol’ [4], and to European recommendations 
[5, 6].
The MGD4,5cmPMMA values were calculated by the for-
mula:
                              MGD4,5cmPMMA = K·g·c·s  (1)
where:
MGD4,5cmPMMA — mean glandular dose for 4.5 cm thick 
PMMA phantom;
K — entrance surface air kerma (without backscatter) at the 
upper surface of the breast;
g, c, s — conversion factors determined by Dance et al. [4] 
using Monte Carlo techniques.
The measurements were performed at parameter set-
tings used routinely for mammography examinations. The 
MGD4,5cmPMMA values were compared to the limit values in 
the European recommendations [5, 6]. For this study, the 
MGD4,5cmPMMA values determined in 2007 and 2011–2013 
were analysed. 
Data analysis
Using the 2011–2014 data, the proportional use of the 
various systems employed in Poland were determined. 
Based on the number of mammography units quality con-
trolled in a given year, a linear projection trend of SF systems 
being replaced by the CR and DR systems was determined. 
Thus the trend enabled the year to be established at which 
the last SF system is to disappear; assuming a continuing 
like trend in the future. For each year, the mean, standard 
deviation and minimum and maximum MGD4,5cmPMMA val-
ues for all the mammography systems were calculated. The 
mammography systems were divided into three groups: SF, 
CR and DR where likewise the means, standard deviations, 
and minimum and maximum values of MGD4,5cmPMMA were 
calculated. Additionally, the mean value of MGD4,5cmPMMA 
in the year when all SF systems would be replaced, was 
calculated. 
To allow comparison of MGD4,5cmPMMA values for different 
systems, outcomes per year were divided into three groups 
consisting of firstly SF and CR systems, secondly CR and DR 
systems and thirdly the SF and DR systems. For statistical 
analysis a baseline assumption was made that the mean 
value for each group was the same. For evaluating the vari-
ance differences between different groups, a F-Snedecor 
test was used. A p < 0.05 was considered statistically signif-
icant. After establishing that the variances in all groups were 
the same, the t-student test was performed at the level of 
a = 0.05. In cases where the variances in both analysed groups 
were different, a statistical Cochran-Crox test was used.
Results and discussion
The number of mammography systems used during 
the 5-year study period increased by 32% compared to the 
number of systems starting in 2007 which was 298. Dur-
ing 2011–2014, the number of mammography units was 
about 400 and remained at the same level (Tab. I). Only 
the proportions of the different system types changed. In 
Figure 1, the proportions of SF, CR, and DR systems used for 
the screening program in Poland, in 2007 and 2011–2014 
are presented. Over time the number of SF systems has 
diminished compared to the CR and DR systems. In 2007, 
SFs constituted 97% of operating systems but in 2014 this 
decreased to 56%. The proportion of CR systems in 2007 
was only 1%, but by the end of 2014 this rose to 29%. In 
2007 the proportion of DR systems was only 2% but rose 
to 15% in 2014. There were almost twice more CR systems 
than DR systems in 2014 due to the former’s lower price and 
easier adaptation of existing systems to CR rather than to DR 
systems. Assuming that the trend of replacing SF systems 
with CR and DR systems continues, SF systems will be absent 
from mammography screening in Poland by 2022 (Fig. 2). 
The CR to DR system ratio would at such time be 2.5, thus 
favouring a large advantage of CR over DR systems.
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Table I. MGD4,5cmPMMA mean values, standard deviations, minimum and maximum dose values for all mammography system types for 2007 and 2011–2013
MGD4,5cmPMMA [mGy]
Year Number of 
mammography units
Mean value Standard deviation Minimum value Maximum value
2007 299 1.94 0.72 0.55 4.76
2011 391 1.49 0.43 0.70 6.63
2012 405 1.42 0.36 0.53 3.20
2013 400 1.48 0.39 0.30 2.50
Figure 1. Proportions of different mammography systems for the screening program in Poland in 2007, 2011, 2012, 2013 and 2014
Figure 2. Actual and forecasted (2015–2013) numbers of SF, CR, and DR systems used for the mammography screening program in Poland
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Histograms of MGD4,5cmPMMA values from 2007, 2011, 
2012 and 2013 indicate a consecutive dose decrease (Fig. 3) 
observed for all the three mammography systems. The scale 
on the x-axis is the same for all histograms so that differ-
ences in MGD4,5cmPMMA distributions can be demonstrated 
between years. When comparing MGD4,5cmPMMA values for all 
systems in 2007 to 2013, then the mean value in 2013 was 
1.48 mGy, which is about 24% lower than that in 2007 (Tab. I).
In Table I, the MGD4,5cmPMMA mean values, standard 
deviations, minimum and maximum values for all system 
types in 2007 and 2011–2013 are presented. Comparing 
the MGD4,5cmPMMA mean values between the various system 
types (Tab. II) indicates that those for CR systems were higher 
than for SF systems: by 25% in 2011, by 26% in 2012, and by 
28% in 2013. The MGD4,5cmPMMA mean values for DR systems 
were higher than for SF systems in subsequent years by 
Table II. MGD4,5cmPMMA mean values, standard deviations, minimum and maximum dose values for different mammography system types for 2007 and 
2011–2013
MGD4.5cmPMMA [mGy]
Year Type of detector Number of 
mammography units
Mean value Standard deviation Minimum value Maximum value
2011 SF 302 1.41 0.37 0.74 3.63
CR 51 1.89 0.52 0.70 3.40
DR 38 1.65 0.43 0.80 2.30
2012 SF 293 1.33 0.29 0.68 2.29
CR 69 1.79 0.37 1.00 3.20
DR 43 1.38 0.42 0.53 2.80
2013 SF 241 1.35 0.29 0.63 2.15
CR 103 1.88 0.35 1.00 2.50
DR 56 1.42 0.32 0.90 2.30
Figure 3. Histograms of MGD4,5cmPMMA values for all mammography systems used in Poland for 2007, 2011, 2012, and 2013
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respectively 15%, 4% and 5% whereas the MGD4,5cmPMMA 
mean values for CR systems were higher than for DR systems 
in subsequent years by respectively 13%, 23% and 24%. In 
all cases, the MGD4,5cmPMMA mean values were within the 
acceptable level of 2.5 mGy. When analyzing individual 
cases it was found that MGD values in 2011 exceeded the 
acceptable level in 14 SF systems and 1 CR system, whilst 
in 2012 this occurred only in 1 CR system. In 2013, MGD 
values did not exceed the 2.5 mGy at any time. A comparison 
between those system 2011 and 2013 results exceeding the 
acceptable level revealed that 1 SF system and 1 CR system 
had been taken out of service, however the exposure condi-
tions for remaining CR systems were changed so that MGD 
values stayed within the acceptable limit. Nevertheless, the 
maximum values for CR systems were 16.8% higher than for 
SF systems and 8.7 % higher than for DR systems, whilst the 
DR values were 7% higher than for SF systems.
According to the European recommendations [5, 6], 
every mammography facility should endeavour to keep 
values of the mean glandular dose (termed MGD) at an 
achievable level of 2 mGy. In the literature, MGD4,5cmPMMA 
values for DR systems are stated not to exceed 2.0 mGy per 
exposure [7–11]. Our data indicate that in 2011 the achiev-
able level was exceeded by 15 SF systems (~5%), 18 CR 
systems (~35%), and 10 DR systems (~10%). In 2012, the 
achievable level was exceeded by 9 SF systems (~3%), 15 CR 
systems (~22%), and 3 DR systems (~7%) whereas in 2013, 
the achievable level was exceeded for 7 SF systems (~3%), 
30 CR systems (~29%), and 2 DR systems (~4%). 
Statistically significant differences in MGD4,5cmPMMA 
mean values were found between SF and CR systems and 
between DR and CR systems, however such differences were 
insignificant between SF and DR systems. This means that 
during 2011–2013, the MGD4,5cmPMMA mean values for CR 
systems were significantly different from the MGD4,5cmPMMA 
mean values for both SF and DR systems. Literature data 
indicate that mean MGD values for DR systems are about 
32% lower than for SF systems, and those for CR systems are 
close to the values for SF systems [12]. Young et al. showed 
that MGD values for DR systems were lower by 25% than 
those for SF systems [13]. Similar results have been shown 
by Hendrik et al. [14]. 
MGD values presented in this paper clearly differ from 
those in the literature but it is difficult to definitively account 
for such discrepancies. Nevertheless, our results indicate that 
it is possible to decrease X ray doses in the mammography 
screening in Poland, especially for CR systems. Most likely 
this would require optimising the exposure parameters 
taking into account the image quality, and perhaps even 
individually modernising the mammography equipment for 
every system. In an earlier study [15], the present authors 
described an attempt to optimize exposure parameters for 
increasing the MGD value and to maintain image quality. 
Although such attempts were directed to the DR systems, 
they may also be applied to CR systems. 
Assuming that the the number of mammography units 
until 2022 grows at the same rate as during 2011–2014, then 
the MGD4,5cmPMMA mean value in 2022 was estimated to be 
1.66 mGy. Such a MGD4,5cmPMMA mean value would in fact 
be about 12% larger than the MGD4,5cmPMMA mean value for 
all mammography systems in Poland in 2013.
Conclusions
MGD4,5cmPMMA mean values differ according to the detec-
tion system used for mammography screening in Poland. 
For CR systems they are significantly higher than for SF and 
DR systems. In order to adhere to the ALARA principle, it 
appears necessary to make every effort to decrease current 
MGD4,5cmPMMA mean values, especially for CR systems.
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